Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Holly Geyer, Keith Cannon, Emily Knight, Veena Fauble, John Camoriano, Robyn Emanuel, Raoul Tibes, Ruben Mesa

Research output: Contribution to journalLetter

17 Scopus citations
Original languageEnglish (US)
Pages (from-to)195-197
Number of pages3
JournalLeukemia and Lymphoma
Volume55
Issue number1
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this